巴克莱对10x基因组学公司(TXG)转为更乐观态度,尽管研究支出波动——雅虎财经英国版
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Yahoo Finance UK
生物技术与制药领域的最新动态
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending - Yahoo Finance UK
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - Nasdaq
10x Genomics (TXG) Stock Trades Up, Here Is Why - Finviz
Why 10x Genomics Stock Is Suddenly Surging - TipRanks
10x Genomics (TXG) Stock Trades Up, Here Is Why - Yahoo Finance
10x Genomics (TXG) Stock Trades Up, Here Is Why - TradingView — Track All Markets
10x Genomics (TXG) Stock Trades Up, Here Is Why - FinancialContent
10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus
10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus
10x Genomics (NASDAQ:TXG) Given New $20.00 Price Target at Canaccord Genuity Group - MarketBeat
Lancaster Investment Management Purchases Shares of 621,779 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock a safe haven asset - Quarterly Performance Summary & Technical Confirmation Alerts - DonanımHaber
Executive Q&A Video: SPT Labtech and 10x Genomics on Automating Single-Cell Workflows - GenomeWeb
BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Announces Target Price $18 - 富途牛牛
10x Genomics price target raised to $22 from $17 at Barclays - TipRanks
Spatial Transcriptomics Market Is Going to Boom |• 10X Genomics • Illumina - openPR.com
10x Genomics $TXG Position Increased by Nikko Asset Management Americas Inc. - MarketBeat
Why The Narrative Around 10x Genomics Is Shifting After New Institutional Buying And Product Updates - Yahoo Finance
Bellevue Group AG Buys 95,754 Shares of 10x Genomics $TXG - MarketBeat
Citi downgrades 10x Genomics (TXG) to a Hold - The Globe and Mail